Document:

Unassociated Document

    
      
        Exhibit
10.1 Weyerhaeuser Company 2004 Long-Term Incentive Plan Stock Option Award Terms
and Conditions

         

        

        
          	
                  WEYERHAEUSER COMPANY

                
	
                  2004
      LONG-TERM INCENTIVE PLAN

                

        

        
          	
                   

                  STOCK
      OPTION TERMS AND CONDITIONS

                

        

        Pursuant
to your Stock Option Grant Notice (the “Grant Notice”) and these Stock Option
Terms and Conditions, Weyerhaeuser Company has granted you an Option under its
2004 Long-Term Incentive Plan (the “Plan”) to purchase the number of shares of
the Company's Common Stock indicated in your Grant Notice (the “Shares”) at the
exercise price indicated in your Grant Notice.  You may decline this
Grant by notifying sally.wagner@weyerhaeuser.com
within one month of the grant date.

        Capitalized
terms not explicitly defined in this document but defined in the Plan have the
definitions given to such terms in the Plan.  The Option is granted to
you as a participant in the Plan and is subject to the terms and conditions set
out in the Plan.  In addition, the Option has the following terms and
conditions:

         

        1.           Vesting.  The Option
will vest and become exercisable on the four-year anniversary of the Grant
Date.  No part of the Option will be exercisable until the -four-year
anniversary of the Grant Date.  As of the fourth anniversary of the
Grant Date, 100% of the Option will be vested and exercisable.

        

        2.           Term.  The Options
will expire at the time specified in your Grant Notice.  Following
that date, you will no longer be able to exercise the Option.  In
addition, the Option may terminate earlier than the tenth anniversary if your
employment with Weyerhaeuser Company ceases for any reason.  Transfer
of employment between or among the Company and its subsidiaries is not
considered termination of employment.  Options that are not vested
before their expiration date are forfeited and without value.

        

        3.           Change in Option Term as a Result of
Termination of Employment.  If your employment terminates
before the Option has expired, the length of time during which you have a right
to exercise the Option varies depending on the reason for termination of
employment.

        

        (a)           Termination as a
result of death of the Participant.  During your lifetime, this
Option may be exercised only by you.  If you die while actively
employed, your Option is automatically 100% vested and your beneficiary or
personal representative may exercise the Option at any time or from time to time
within a maximum of two years after your date of death, or during the remaining
term of the grant if that is a shorter period of time.

        

        (b)           Termination of
Employment upon Retirement.  If you qualify for retirement at
the time of termination (after reaching age 65 or after reaching age 62 with ten
(10) years or more of Vesting Service as defined in the Weyerhaeuser Company
Retirement Plan for Salaried Employees), any portion of your Option that is not
vested is forfeited and no longer has any value. For any portion of your option
that has vested as of the date of your termination, you will be able to exercise
the Option for the remaining term of the grant, up to a maximum of 10
years.

        

        
          
             

          

          
             

            
              

            

          

          
             

          

        

        (c)           Termination of
employment upon Early Retirement. If you retire before age 62, but not
earlier than your 55th
birthday and you also have accrued a total of 10 years of Vesting Service (as
defined in the Weyerhaeuser Company Retirement Plan for Salaried Employees)
(“Early Retirement”), any portion of your Option that is not vested is forfeited
and no longer has any value.  For any portion of your option that has
vested as of the date of your termination, you will be able to exercise your
Option within a maximum of five years from your termination date, or during the
remaining term of the grant if that is a shorter period of time.

        

        (d)           Termination
of employment upon Disability Retirement.  In addition, if you
do not qualify for Retirement or Early Retirement, but retire as a result of a
Disability, the onset of which occurred on or after the date you had accrued 10
years of Vesting Service (“Disability Retirement”), your Option will
automatically be 100% vested on the date of your termination and you will be
able to exercise your Option within a maximum of five years from your
termination date, or during the remaining term of the grant if that is a shorter
period of time.

         

        “Disability”
means “a medical condition in which a person is either entitled to total and
permanent disability benefits under the Social Security Act or judged to be
totally and permanently disabled by any person or committee entitled to make
such determinations pursuant to the Company’s Retirement Plan for Salaried
Employees.

        

        (e)           Termination of
Employment Due to Disability.  If your employment is terminated
as a result of Disability, your Option will automatically be 100% vested at your
termination date and you will be able to exercise your Option within a maximum
of three years from the date of termination, or during the remaining term of the
grant if that is a shorter period of time.

        

        (f)           Termination of
Employment Due to Position Elimination.  If your employment is
terminated as a result of position elimination, a portion of your Option will
vest as of the date of termination. The number of shares that vest will be
determined as the number of days of employment with the Company from the Grant
Date through the date of termination divided by 1460.  You will be
able to exercise vested Options within a maximum of three years from the date of
termination, or during the remaining term of the grant if that is a shorter
period of time.

        

        (g)           Termination of
Employment for Reason Other than death, Position Elimination, Retirement, Early
Retirement, Disability Retirement or Disability. If your employment is
terminated for any reason other than death, position elimination, Retirement,
Early Retirement, Disability Retirement or Disability and your Option is not
vested it is forfeited and no longer has any value.  For any portion
of your Option that has vested as of the date of your termination, you will be
able to exercise your Option for a maximum of three calendar months from the
date of termination, or during the remaining term of the grant if that is a
shorter period of time.

        
          	
                   

                  (f)           Termination
      of Employment for Cause.  The vested portion of the
      Option will automatically expire at the time the Company first notifies
      you of your Termination for Cause, unless the Committee determines
      otherwise.  If your employment or service relationship is
      suspended pending an investigation of whether you will be terminated for
      Cause, all your rights under the Option likewise will be suspended during
      the period of investigation.  If any facts that would constitute
      termination for Cause are discovered after your Termination of Service,
      any Option you then hold may be immediately terminated by the
      Committee.

                

        

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

        “Cause”
means: (i) willful and continued failure to perform substantially your
duties with the Company after the Company delivers to you written demand for
substantial performance specifically identifying the manner in which you have
not substantially performed your duties; (ii) conviction of a felony; or
(iii) willfully engaging in illegal conduct or gross misconduct that is
materially and demonstrably injurious to the Company.

         

        
          	
                  To
      qualify for the beneficial tax treatment afforded Incentive Stock Options,
      the Option must be exercised within three months after termination of
      employment for reasons other than death or Disability and one year after
      termination of employment due to
Disability.

                

        

        It
is your responsibility to be aware of the date the Option
terminates.

        

        4.           Securities Law
Compliance.  Notwithstanding any other provision of this grant,
you may not exercise the Option unless the Shares issuable upon exercise are
registered under the Securities Act or if the Company has determined that such
exercise and issuance would be exempt from the registration requirements of the
Securities Act.  The exercise of the Option must also comply with
other applicable laws and regulations governing the Option, and you may not
exercise the Option if the Company determines that such exercise would not be in
compliance with such laws and regulations.

        

        5.           Incentive Stock Option
Qualification.  If your Option is
designated as an Incentive Stock Option in your Grant Notice, all or a portion
of the Option is intended to qualify as an Incentive Stock Option under federal
income tax law.  However, the Company does not represent or guarantee
that the Option qualifies as such.

        

        If the
Option has been designated as an Incentive Stock Option and the aggregate Fair
Market Value (determined as of the grant date) of the shares of Common Stock
subject to the portions of the Option and all other Incentive Stock Options you
hold that first become exercisable during any calendar year exceeds $100,000,
any excess portion will be treated as a Nonqualified Stock Option, unless the
Internal Revenue Service changes the rules and regulations governing the
$100,000 limit for Incentive Stock Options.  In addition, a portion of
the Option may be treated as a Nonqualified Stock Option if certain events cause
exercisability of the Option to accelerate.

        

        6.           Notice of Disqualifying
Disposition.  To the extent the Option has been designated as
an Incentive Stock Option, to obtain certain tax benefits afforded to Incentive
Stock Options, you must hold the Shares issued upon the exercise of the Option
for two years after the Grant Date and one year after the date of
exercise.  If shares of stock obtained upon exercise of an Incentive
Stock Option are tendered to pay the exercise price for another option less than
one year after the exercise date of the Incentive Stock Option, the tender will
be considered a disqualifying disposition.  You may be subject to the
alternative minimum tax at the time of exercise.  You should obtain
tax advice when exercising the Option and prior to the disposition of the
Shares.  By accepting an Option designated as an Incentive Stock
Option, you agree to promptly notify the Company if you dispose of any of the
Shares within one year from the date you exercise all or part of the Option or
within two years from the Grant Date.

        

        7.           Method of
Exercise.  You may exercise the Option by giving notice to the
Company or a brokerage firm designated or approved by the Company, in form and
substance satisfactory to the Company, which will state your election to
exercise the Option and the number of Shares for which you are exercising the
Option.  The notice must be accompanied by full payment of the
exercise price for the number of Shares you are purchasing.  You may
make this payment in any combination of the following:  (a) by
cash; (b) by check acceptable to the Company; (c) by tendering (either
actually or by attestation) shares of Common Stock you have owned for at least
six months (if such holding period is necessary to avoid a charge to the
Company's earnings); (d) to the extent permitted by law, by instructing a
broker to deliver to the Company the total payment required in accordance with
procedures established by the Company; or (e) by any other method permitted
by the Committee.

        

        
          
             

          

          
             

            
              

            

          

          
             

          

        

        8.           Withholding Taxes. As a condition to the
exercise of any portion of an Option, you must make such arrangements as the
Company may require for the satisfaction of any federal, state, local or foreign
withholding tax obligations that may arise in connection with such
exercise.

        

        9.           Option Not an Employment or Service
Contract.  Nothing in the Plan or any Award granted under the
Plan will be deemed to constitute an employment contract or confer or be deemed
to confer any right for you to continue in the employ of, or to continue any
other relationship with, the Company or any Related Company or limit in any way
the right of the Company or any Related Company to terminate your employment or
other relationship at any time, with or without Cause.

        

        10.           No Right to
Damages.  You will have no right to bring a claim or to receive
damages if you are required to exercise the vested portion of the Option within
three months (one year in the case of Retirement, Disability or death) of the
Termination of Service or if any portion of the Option is cancelled or expires
unexercised.  The loss of existing or potential profit in Awards will
not constitute an element of damages in the event of your Termination of Service
for any reason even if the termination is in violation of an obligation of the
Company or a Related Company to you.

        

        11.           Binding Effect.  The
terms and conditions of this grant will inure to the benefit of the successors
and assigns of the Company and be binding upon you and your heirs, executors,
administrators, successors and assigns.

        

        12.           Limitation on Rights; No Right to
Future Grants; Extraordinary Item of
Compensation.  (a) The Plan is discretionary in nature and
may be suspended or terminated by the Company at any time; (b) The grant of
the Option is a one-time benefit that does not create any contractual or other
right to receive future grants of options, or benefits in lieu of options;
(c) All determinations with respect to any such future grants, including,
but not limited to, the times when options will be granted, the number of shares
subject to each option, the option price, and the time or times when each option
will be exercisable, will be at the sole discretion of the Company;
(d) Your participation in the Plan is voluntary; (e) The value of the
Option is an extraordinary item of compensation that is outside the scope of
your employment contract, if any; (f) The Option is not part of normal or
expected compensation for purposes of calculating any severance, resignation,
redundancy, end of service payments, bonuses, long-service awards, pension or
retirement benefits or similar payments; (g) The vesting of the Option
ceases upon your Termination of Service for any reason except as may otherwise
be explicitly provided in the Plan, the terms and conditions of this grant, or
otherwise permitted by the Committee; (h) The future value of the Shares
underlying the Option is unknown and cannot be predicted with certainty; and
(i) If the Shares underlying the Option do not increase in value, the
Option will have no value.

        

        13.           Employee Data
Privacy.  By receiving this award, you (a) authorize the
Company and your employer, if different, and any agent of the Company
administering the Plan or providing Plan recordkeeping services, to disclose to
the Company or any of its affiliates any information and data the Company
requests in order to facilitate the grant of the Option and the administration
of the Plan; (b) waive any data privacy rights you may have with respect to such
information; and (c) authorize the Company and its agents to store and
transmit such information in electronic
form.SECURITIES
PURCHASE AGREEMENT

       

      This
Securities Purchase Agreement (this "AGREEMENT") is dated as of _______ ___,
2009, among Sanswire Corp., a Delaware corporation (the "COMPANY"), and the
purchasers identified on the signature pages hereto (each a "PURCHASER" and
collectively the "PURCHASERS"); and

       

      WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to
Section 4(2) of the Securities Act (as defined below), and Rule 506 promulgated
thereunder, the Company desires to issue and sell to the Purchasers, and the
Purchasers, severally and not jointly, desires to purchase from the Company in
the aggregate, up to $250,000 of the Companies 7% Convertible Debentures on the
Closing Date.

       

      NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement,
and for other good and valuable consideration the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agrees as
follows:

       

      ARTICLE
I. DEFINITIONS

       

      1.1
DEFINITIONS. In addition to the terms defined elsewhere in this Agreement, for
all purposes of this Agreement, the following terms have the meanings indicated
in this Section 1.1:

       

      "ACTION"
shall have the meaning ascribed to such term in Section 3.1(j).

       

      "AFFILIATE"
means any Person that, directly or indirectly through one or more
intermediaries, controls or is controlled by or is under common control with a
Person as such terms are used in and construed under Rule 144. With respect to a
Purchaser, any investment fund or managed account that is managed on a
discretionary basis by the same investment manager as such Purchaser will be
deemed to be an Affiliate of such Purchaser.

       

      "BUSINESS
DAY" means any day except Saturday, Sunday and any day which shall be a federal
legal holiday or a day on which banking institutions in the State of New York
are authorized or required by law or other governmental action to
close.

       

      "CLOSING"
means the closing of the purchase and sale of the Common Stock and the Warrants
pursuant to Section 2.1.

       

      "CLOSING
DATE" means the Trading Day when all of the Transaction Documents have been
executed and delivered by the applicable parties thereto, and all conditions
precedent to (i) the Purchasers' obligations to pay the Subscription Amount and
(ii) the Company's obligations to deliver the Securities have been satisfied or
waived.

       

      "CLOSING
PRICE" means on any particular date (a) the last reported closing bid price per
share of Common Stock on such date on the Trading Market (as reported by
Bloomberg L.P. at 4:15 PM (New York time), or (b) if there is no such price on
such date, then the closing bid price on the Trading Market on the date nearest
preceding such date (as reported by Bloomberg L.P. at 4:15 PM (New York time)
for the closing bid price for regular session trading on such day), or (c) if
the Common Stock is not then listed or quoted on the Trading Market and if
prices for the Common Stock are then reported in the "pink sheets" published by
the National Quotation Bureau Incorporated (or a similar organization or agency
succeeding to its functions of reporting prices), the most recent bid price per
share of the Common Stock so reported, or (d) if the shares of Common Stock are
not then publicly traded the fair market value of a share of Common Stock as
determined by an appraiser selected in good faith by the Purchasers of a
majority in interest of the Shares then outstanding.

       

      "COMMISSION"
means the Securities and Exchange Commission.

       

      "COMMON
STOCK" means the common stock of the Company, $0.00001 par value per share, and
any securities into which such common stock may hereafter be
reclassified.

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      "COMMON
STOCK EQUIVALENTS" means any securities of the Company or the Subsidiaries which
would entitle the holder thereof to acquire at any time Common Stock, including
without limitation, any debt, preferred stock, rights, options, warrants or
other instrument that is at any time convertible into or exchangeable for, or
otherwise entitles the holder thereof to receive, Common Stock.

       

      "DISCLOSURE
SCHEDULES" means the Disclosure Schedules delivered concurrently
herewith.

       

      "EFFECTIVE
DATE" means the date that a Registration Statement covering the shares sold
hereunder (or for which there is a conversion pursuant hereto is first declared
effective by the Commission or such time that such shares are eligible for
resale pursuant to Rule 144.

       

      "EXCHANGE
ACT" means the Securities Exchange Act of 1934, as amended.

       

      "INTELLECTUAL
PROPERTY RIGHTS" shall have the meaning ascribed to such term in Section
3.1(o).

       

      "LIENS"
means a lien, charge, security interest, encumbrance, right of first refusal,
preemptive right or other restriction.

       

      "MATERIAL
ADVERSE EFFECT" shall have the meaning ascribed to such term in Section
3.1(b).

       

      "MATERIAL
PERMITS" shall have the meaning ascribed to such term in Section
3.1(m).

       

      "PER
SHARE CONVERSION PRICE" equals $.105 subject to adjustment for reverse and
forward stock splits, stock dividends, stock combinations and other similar
transactions of the Common Stock that occur after the date of this Agreement.
However, if after 90 days from the date hereof the market price of the Company’s
common shares during the 90 day period has not closed at a bid price at or above
$.12 per share for 3 or more consecutive trading days. In such instance then the
Investors’s price per share shall be equal to the average closing bid price for
the last 30 trading days immediately prior to the 90th day
after the date of this addendum. Should the price of the common shares be $.105
or higher on the 90th day
after the date of this addendum, then the purchase price per share shall remain
at $.105 per share.  Should the Market Price of the shares be $.105 or
higher on the 90th day
after the date of this addendum, but less than $.125, then the Investor shall be
entitled to an amount of additional shares equal to 10% of the number of shares
to which the Investor is otherwise entitled.

       

      "PERSON"
means an individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability company, joint
stock company, government (or an agency or subdivision thereof) or other entity
of any kind.

       

      "PROCEEDING"
means an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.

       

      "REQUIRED
APPROVALS" shall have the meaning ascribed to such term in Section
3.1(e).

       

      "RULE
144" means Rule 144 promulgated by the Commission pursuant to the Securities
Act, as such Rule may be amended from time to time, or any similar rule or
regulation hereafter adopted by the Commission having substantially the same
effect as such Rule.

       

      "SEC
REPORTS" shall have the meaning ascribed to such term in Section
3.1(h).

       

      "SECURITIES"
means the Shares, the Warrants and the Warrant Shares.

       

      "SECURITIES
ACT" means the Securities Act of 1933, as amended.

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      "SHARES"
means the shares of Common Stock issued or issuable to each Purchaser pursuant
to this Agreement.

       

      "SUBSCRIPTION
AMOUNT" means, as to each Purchaser, the amounts set forth below such
Purchaser's signature block on the signature page hereto, in United States
dollars and in immediately available funds.

       

      "SUBSIDIARY"
shall mean the subsidiaries of the Company, if any, set forth on Schedule
3.1(a).

       

      "TRADING
DAY" means (i) a day on which the Common Stock is traded on a Trading Market, or
(ii) if the Common Stock is not quoted on a Trading Market, a day on which the
Common Stock is quoted in the over-the-counter market as reported by the
National Quotation Bureau Incorporated (or any similar organization or agency
succeeding its functions of reporting prices); provided, that in the event that
the Common Stock is not listed or quoted as set forth in (i) and (ii) hereof,
then Trading Day shall mean a Business Day.

       

      "TRADING
MARKET" means the following markets or exchanges on which the Common Stock is
listed or quoted for trading on the date in question: The Pink Sheets the OTC
Bulletin Board, the American Stock Exchange, the New York Stock Exchange, the
Nasdaq National Market or the Nasdaq SmallCap Market.

       

      "TRANSACTION
DOCUMENTS" means this Agreement, the Warrants and the Convertible Note and any
other documents or agreements executed in connection with the transactions
contemplated hereunder.

       

      "WARRANTS"
means the Common Stock Purchase Warrants, in the form of EXHIBIT C, issuable to
the Purchasers at the Closing, which warrants shall be exercisable immediately
upon issuance for a term of 36 months and have an exercise price equal to $.21
and $.315, except as adjusted as per below “Warrant Shares.”

       

      "WARRANT
SHARES" means the shares of Common Stock issuable upon exercise of the Warrants.
The number of Warrant Shares shall be equal to 100% of the number of shares
purchased by the Purchaser, with 50% of such warrants having an exercise price
of $.21 and 50% of such warrants having an exercise price of .315. However, If
the Investors’ price per share is adjusted pursuant to the above definition of
“Purchase Price”, the $.21 warrant price shall be adjusted to double the
adjusted share price and the $.315 warrant price shall be adjusted to triple the
adjusted share price.

       

      ARTICLE
II. PURCHASE AND SALE2.1 CLOSING.

       

      On the
First Closing Date, each Purchaser shall purchase from the Company, severally
and not jointly with the other Purchasers, and the Company shall issue and sell
to each Purchaser, (a) a Convertible Note equal to such Purchaser's Subscription
Amount and (b) the Warrants as determined pursuant to Section 2.2(a)(iii). The
aggregate Subscription Amounts for Shares sold hereunder shall be up to
$250,000. Upon satisfaction of the conditions set forth in Section 2.2, the
Closing shall occur at the offices of Company Counsel or such other location as
the parties shall mutually agree.

       

      2.2
CLOSING CONDITIONS; DELIVERIES.

       

      (a) On
the Closing Date, the Company shall deliver or cause to be delivered to each
Purchaser the following:

       

      (i) this
Agreement duly executed by the Company;

       

      (ii) a
Convertible Note equal to such Purchaser's Subscription Amount in the name of
such Purchaser; and

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      (iii) a
Warrant, registered in the name of such Purchaser, pursuant to which such
Purchaser shall have the right to acquire up to the number of shares of Common
Stock equal to 50% of the Shares to be issued to such Purchaser at the Closing
at a price of $.21 per share and the number of shares of Common Stock equal to
50% of the Shares to be issued to such Purchaser at the Closing at a price of
$.315 per share, subject to adjustment as set forth in the definition of
warrant, above.

       

      (b) On
the Closing Date, each Purchaser shall deliver or cause to be delivered to the
Company the following:

       

      (i) this
Agreement duly executed by such Purchaser;

       

      (ii) such
Purchaser's Subscription Amount by wire transfer to the account of the Company;
and

       

      (iii) the
Registration Rights Agreement duly executed by such Purchaser.

       

      (c) All
representations and warranties of the other party contained herein shall remain
true and correct as of the Closing Date.

       

      (d) All
obligations, covenants and agreements of the parties required to be performed at
or prior to the Closing Date shall have been performed.

       

      (e) From
the date hereof to the Closing Date, trading in the Common Stock shall not have
been suspended by the Commission, and, at any time prior to the Closing Date,
trading in securities generally as reported by Bloomberg Financial Markets shall
not have been suspended or limited, or minimum prices shall not have been
established on securities whose trades are reported by such service, or on any
Trading Market, nor shall a banking moratorium have been declared either by the
United States or New York State authorities nor shall there have occurred any
material outbreak or escalation of hostilities or other national or
international calamity of such magnitude in its effect on, or any material
adverse change in, any financial market which, in each case, in the reasonable
judgment of each Purchaser, makes it impracticable or inadvisable to purchase
the Shares at the such Closing.

       

      ARTICLE
III. REPRESENTATIONS AND WARRANTIES

       

      3.1
REPRESENTATIONS AND WARRANTIES OF THE COMPANY. Except as set forth under the
corresponding section of the Disclosure Schedules delivered concurrently
herewith, the Company hereby makes the following representations and warranties
as of the date hereof and as of the Closing Date to each Purchaser:

       

      (a)
SUBSIDIARIES. All of the subsidiaries of the Company are set forth on SCHEDULE
3.1(a). The Company owns, directly or indirectly, all of the capital stock or
other equity interests of each Subsidiary free and clear of any Liens, and all
the issued and outstanding shares of capital stock of each Subsidiary are
validly issued and are fully paid, non-assessable and free of preemptive and
similar rights to subscribe for or purchase securities. If the Company has no
subsidiaries, then references in the Transaction Documents to the Subsidiaries
will be disregarded.

       

      (b)
ORGANIZATION AND QUALIFICATION. Each of the Company and the Subsidiaries is an
entity duly incorporated or otherwise organized, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or organization
(as applicable), with the requisite power and authority to own and use its
properties and assets and to carry on its business as currently conducted.
Neither the Company nor any Subsidiary is in violation or default of any of the
provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the
Subsidiaries is duly qualified to conduct business and is in good standing as a
foreign corporation or other entity in each jurisdiction in which the nature of
the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as
the case may be, could not have or reasonably be expected to result in (i) a
material adverse effect on the legality, validity or enforceability of any
Transaction Document, (ii) a material adverse effect on the results of
operations, assets, business, prospects or financial condition of the Company
and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on
the Company's ability to perform in any material respect on a timely basis its
obligations under any Transaction Document (any of (i), (ii) or (iii), a
"MATERIAL ADVERSE EFFECT") and no Proceeding has been instituted in any such
jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or
curtail such power and authority or qualification.

       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      (c)
AUTHORIZATION; ENFORCEMENT. The Company has the requisite corporate power and
authority to enter into and to consummate the transactions contemplated by each
of the Transaction Documents and otherwise to carry out its obligations
thereunder. The execution and delivery of each of the Transaction Documents by
the Company and the consummation by it of the transactions contemplated thereby
have been duly authorized by all necessary action on the part of the Company and
no further action is required by the Company in connection therewith other than
in connection with the Required Approvals. Each Transaction Document has been
(or upon delivery will have been) duly executed by the Company and, when
delivered in accordance with the terms hereof, will constitute the valid and
binding obligation of the Company enforceable against the Company in accordance
with its terms except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting
enforcement of creditors' rights generally and (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other
equitable remedies.

       

      (d) NO
CONFLICTS. The execution, delivery and performance of the Transaction Documents
by the Company, the issuance and sale of the Shares and the consummation by the
Company of the other transactions contemplated thereby do not and will not (i)
conflict with or violate any provision of the Company's or any Subsidiary's
certificate or articles of incorporation, bylaws or other organizational or
charter documents, or (ii) conflict with, or constitute a default (or an event
that with notice or lapse of time or both would become a default) under, result
in the creation of any Lien upon any of the properties or assets of the Company
or any Subsidiary, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of,
any agreement, credit facility, debt or other instrument (evidencing a Company
or Subsidiary debt or otherwise) or other understanding to which the Company or
any Subsidiary is a party or by which any property or asset of the Company or
any Subsidiary is bound or affected, or (iii) subject to the Required Approvals,
conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal and
state securities laws and regulations), or by which any property or asset of the
Company or a Subsidiary is bound or affected, or (iv) conflict with or violate
the terms of any agreement by which the Company or any Subsidiary is bound or to
which any property or asset of the Company or any Subsidiary is bound or
affected; except in the case of each of clauses (ii) and (iii), such as could
not have or reasonably be expected to result in a Material Adverse
Effect.

       

      (e)
FILINGS, CONSENTS AND APPROVALS. The Company is not required to obtain any
consent, waiver, authorization or order of, give any notice to, or make any
filing or registration with, any court or other federal, state, local or other
governmental authority or other Person in connection with the execution,
delivery and performance by the Company of the Transaction Documents, other than
(i) filings required pursuant to Section 4.6 of this Agreement, (ii) the filing
with the Commission of the Registration Statement, (iii) application(s) to each
applicable Trading Market for the listing of the Shares and Warrant Shares for
trading thereon in the time and manner required thereby, and (iv) the filing of
Form D with the Commission and such filings as are required to be made under
applicable state securities laws (collectively, the "REQUIRED
APPROVALS").

       

      (f)
ISSUANCE OF THE SECURITIES. The Securities are duly authorized and, when issued
and paid for in accordance with the Transaction Documents, will be duly and
validly issued, fully paid and nonassessable, free and clear of all Liens. The
issuance of the Shares is not subject to any preemptive or similar rights to
subscribe for or purchase securities. The Company has reserved from its duly
authorized capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Warrants.

       

      (g)
CAPITALIZATION. Approximately 160,000,000 shares of the Company’s Capital stock
issued and outstanding. All of the outstanding shares of capital stock of the
Company are validly issued, fully paid and nonassessable, have been issued in
compliance with all federal and state securities laws, and none of such
outstanding shares was issued in violation of any preemptive rights or similar
rights to subscribe for or purchase securities. No further approval or
authorization of any stockholder, the Board of Directors of the Company or
others is required for the issuance and sale of the Shares. Except as disclosed
in the SEC Reports, there are no stockholders agreements, voting agreements or
other similar agreements with respect to the Company's capital stock to which
the Company is a party or, to the knowledge of the Company, between or among any
of the Company's stockholders.

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      (h) SEC
REPORTS; FINANCIAL STATEMENTS. The Company hasn’t filed all reports required to
be filed by it under the Securities Act and the Exchange Act, including pursuant
to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof
(or such shorter period as the Company was required by law to file such
material) (the foregoing materials, including the exhibits thereto, being
collectively referred to herein as the "SEC REPORTS") on a timely
basis.

       

      (i)
INTERNAL ACCOUNTING CONTROLS. The Company and each of the Subsidiaries maintains
a system of internal accounting controls sufficient to provide reasonable
assurance that (i) transactions are executed in accordance with management's
general or specific authorizations, (ii) transactions are recorded as necessary
to permit preparation of financial statements in conformity with GAAP and to
maintain asset accountability, (iii) access to assets is permitted only in
accordance with management's general or specific authorization, and (iv) the
recorded accountability for assets is compared with the existing assets at
reasonable intervals and appropriate action is taken with respect to any
differences. The Company has established disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the Company and designed
such disclosure controls and procedures to ensure that material information
relating to the Company, including the Subsidiaries, is made known to the
certifying officers by others within those entities, particularly during the
period in which the Company's most recently filed period report under the
Exchange Act, as the case may be, is being prepared. The Company's certifying
officers have evaluated the effectiveness of the Company's controls and
procedures as of a date within 90 days prior to the filing date of the most
recently filed periodic report under the Exchange Act (such date, the
"EVALUATION DATE"). The Company presented in its most recently filed period
report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their
evaluations as of the Evaluation Date. Since the Evaluation Date, there have
been no significant changes in the Company's internal controls (as such term is
defined in Item 307(b) of Regulation S-K under the Exchange Act) or, to the
Company's knowledge, in other factors that could significantly affect the
Company's internal controls. The Company maintains and will continue to maintain
a standard system of accounting established and administered in accordance with
GAAP and the applicable requirements of the Exchange Act.

       

      (j)
PRIVATE PLACEMENT. Assuming the accuracy of the Purchasers representations and
warranties set forth in Section 3.2, no registration under the Securities Act is
required for the offer and sale of the Securities by the Company to the
Purchasers as contemplated hereby. The issuance and sale of the Securities
hereunder does not contravene the rules and regulations of the Trading
Market.

       

      (k)
INVESTMENT COMPANY. The Company is not, and is not an Affiliate of, and
immediately after receipt of payment for the Shares, will not be or be an
Affiliate of, an "investment company" within the meaning of the Investment
Company Act of 1940, as amended. The Company shall conduct its business in a
manner so that it will not become subject to the Investment Company
Act.

       

      (l)
APPLICATION OF TAKEOVER PROTECTIONS. The Company and its Board of Directors have
not implemented any poison pill (including any distribution under a rights
agreement) or other similar anti-takeover provision under the Company's
Certificate of Incorporation (or similar charter documents) or the laws of its
state of incorporation.

       

      (m)
DISCLOSURE. Other than the terms of the transaction contemplated by this
Agreement, the Company confirms that, neither the Company nor any other Person
acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that constitutes or might constitute material,
non-public information. The Company understands and confirms that the Purchasers
will rely on the foregoing representations and covenants in effecting
transactions in securities of the Company. All disclosure provided to the
Purchasers regarding the Company, its business and the transactions contemplated
hereby, including the Disclosure Schedules to this Agreement, furnished by or on
behalf of the Company are true and correct and do not contain any untrue
statement of a material fact or omit to state any material fact necessary in
order to make the statements made therein, in light of the circumstances under
which they were made, not misleading.

       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      (n) NO
INTEGRATED OFFERING. Assuming the accuracy of the Purchasers' representations
and warranties set forth in Section 3.2, neither the Company, nor any of its
affiliates, nor any Person acting on its or their behalf has, directly or
indirectly, made any offers or sales of any security or solicited any offers to
buy any security, under circumstances that would cause this offering of the
Securities to be integrated with prior offerings by the Company for purposes of
the Securities Act or any applicable shareholder approval provisions, including,
without limitation, under the rules and regulations of any exchange or automated
quotation system on which any of the securities of the Company are listed or
designated.

       

      (o)
GENERAL SOLICITATION. Neither the Company nor any person acting on behalf of the
Company has offered or sold any of the Shares by any form of general
solicitation or general advertising. The Company has offered the Shares for sale
only to the Purchasers and certain other "accredited investors" within the
meaning of Rule 501 under the Securities Act.

       

      (p)
FOREIGN CORRUPT PRACTICES. Neither the Company, nor to the knowledge of the
Company, any agent or other person acting on behalf of the Company, has (i)
directly or indirectly, used any corrupt funds for unlawful contributions,
gifts, entertainment or other unlawful expenses related to foreign or domestic
political activity, (ii) made any unlawful payment to foreign or domestic
government officials or employees or to any foreign or domestic political
parties or campaigns from corporate funds, (iii) failed to disclose fully any
contribution made by the Company (or made by any person acting on its behalf of
which the Company is aware) which is in violation of law, or (iv) violated in
any material respect any provision of the Foreign Corrupt Practices Act of 1977,
as amended.

       

      (q)
ACKNOWLEDGMENT REGARDING PURCHASERS' PURCHASE OF NOTE. The Company acknowledges
and agrees that each of the Purchasers is acting solely in the capacity of an
arm's length purchaser with respect to the Transaction Documents and the
transactions contemplated hereby. The Company further acknowledges that no
Purchaser is acting as a financial advisor or fiduciary of the Company (or in
any similar capacity) with respect to this Agreement and the transactions
contemplated hereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with this Agreement and the
transactions contemplated hereby is merely incidental to the Purchasers'
purchase of the Note. The Company further represents to each Purchaser that the
Company's decision to enter into this Agreement has been based solely on the
independent evaluation of the transactions contemplated hereby by the Company
and its representatives.

       

      3.2
REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS. Each Purchaser hereby, for
itself and for no other Purchaser, represents and warrants as of the date hereof
and as of the Closing Date to the Company as follows:

       

      (a)
ORGANIZATION; AUTHORITY. Such Purchaser is an individual or an entity duly
organized, validly existing and in good standing under the laws of the
jurisdiction of its organization with full right, corporate or partnership power
and authority to enter into and to consummate the transactions contemplated by
the Transaction Documents and otherwise to carry out its obligations thereunder.
The execution, delivery and performance by such Purchaser of the transactions
contemplated by this Agreement have been duly authorized by all necessary
corporate or similar action on the part of such Purchaser. Each Transaction
Document to which it is party has been duly executed by such Purchaser, and when
delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against
it in accordance with its terms, except (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors' rights
generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as
indemnification and contribution provisions may be limited by applicable
law.

      
        
           

        

        
           

          
            

          

        

        
           

        

      

       

      (b)
INVESTMENT INTENT. Such Purchaser understands that the Securities are
"restricted securities" and have not been registered under the Securities Act or
any applicable state securities law and is acquiring the Securities as principal
for its own account for investment purposes only and not with a view to or for
distributing or reselling such Securities or any part thereof, has no present
intention of distributing any of such Securities and has no arrangement or
understanding with any other persons regarding the distribution of such
Securities (this representation and warranty not limiting such Purchaser's right
to sell the Securities pursuant to the Registration Statement or otherwise in
compliance with applicable federal and state securities laws). Such Purchaser is
acquiring the Securities hereunder in the ordinary course of its business. Such
Purchaser does not have any agreement or understanding, directly or indirectly,
with any Person to distribute any of the Securities (this representation and
warranty not limiting such Purchaser's right to sell the Securities pursuant to
the Registration Statement or otherwise in compliance with applicable federal
and state securities laws).

       

      (c)
PURCHASER STATUS. At the time such Purchaser was offered the Securities, it was,
and at the date hereof it is an "accredited investor" as defined in Rule 501(a)
under the Securities Act. Such Purchaser is not required to be registered as a
broker-dealer under Section 15 of the Exchange Act.

       

      (d)
EXPERIENCE OF SUCH PURCHASER. Such Purchaser, either alone or together with its
representatives, has such knowledge, sophistication and experience in business
and financial matters so as to be capable of evaluating the merits and risks of
the prospective investment in the Securities, and has so evaluated the merits
and risks of such investment. Such Purchaser is able to bear the economic risk
of an investment in the Securities and, at the present time, is able to afford a
complete loss of such investment.

       

      (e)
GENERAL SOLICITATION. Such Purchaser is not purchasing the Securities as a
result of any advertisement, article, notice or other communication regarding
the Securities published in any newspaper, magazine or similar media or
broadcast over television or radio or presented at any seminar or any other
general solicitation or general advertisement.

       

      The
Company acknowledges and agrees that each Purchaser does not make or has not
made any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in this Section
3.2.

       

      ARTICLE
IV. OTHER AGREEMENTS OF THE PARTIES

       

      4.1
TRANSFER RESTRICTIONS.

       

      (a) The
Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of Securities other than
pursuant to an effective registration statement or Rule 144, to the Company, to
an Affiliate of a Purchaser or in connection with a pledge as contemplated in
Section 4.1(b), the Company may require the transferor thereof to provide to the
Company an opinion of counsel selected by the transferor, the form and substance
of which opinion shall be reasonably satisfactory to the Company, to the effect
that such transfer does not require registration of such transferred Securities
under the Securities Act. As a condition of transfer, any such transferee shall
agree in writing to be bound by the terms of this Agreement and shall have the
rights of a Purchaser under this Agreement and the Registration Rights
Agreement.

       

      (b) The
Purchasers agree to the imprinting, so long as is required by this Section
4.1(b), of a legend on any of the Securities in the following form:

       

      THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO
SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE ACCEPTABLE TO THE COMPANY. THESE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A
REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN
"ACCREDITED INVESTOR" AS DEFINED IN RULE 501(a) UNDER THE SECURITIES
ACT.

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      The
Company acknowledges and agrees that a Purchaser may from time to time pledge
pursuant to a bona fide margin agreement with a registered broker-dealer or
grant a security interest in some or all of the Securities to a financial
institution that is an "accredited investor" as defined in Rule 501(a) under the
Securities Act and who agrees to be bound by the provisions of this Agreement
and the Registration rights Agreement and, if required under the terms of such
arrangement, such Purchaser may transfer pledged or secured Securities to the
pledgees or secured parties. Such a pledge or transfer would not be subject to
approval of the Company and no legal opinion of legal counsel of the pledgee,
secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser's expense,
the Company will execute and deliver such reasonable documentation as a pledgee
or secured party of Securities may reasonably request in connection with a
pledge or transfer of the Securities, including, if the Securities are subject
to registration pursuant to the Registration Rights Agreement, the preparation
and filing of any required prospectus supplement under Rule 424(b)(3) under the
Securities Act or other applicable provision of the Securities Act to
appropriately amend the list of Selling Stockholders thereunder.

       

      (c)
Certificates evidencing the Shares and Warrant Shares shall not contain any
legend (including the legend set forth in Section 4.1(b)), (i) while a
registration statement (including the Registration Statement) covering the
resale of such security is effective under the Securities Act, or (ii) following
any sale of such Shares or Warrant Shares pursuant to Rule 144, or (iii) if such
Shares or Warrant Shares are eligible for sale under Rule 144, or (iv) if such
legend is not required under applicable requirements of the Securities Act
(including judicial interpretations and pronouncements issued by the Staff of
the Commission). The Company shall cause its counsel to issue a legal opinion to
the Company's transfer agent promptly after the Effective Date if required by
the Company's transfer agent to effect the removal of the legend hereunder. If
all or any portion of a Warrant is exercised at a time when there is an
effective registration statement to cover the resale of the Warrant Shares, such
Warrant Shares shall be issued free of all legends. The Company agrees that
following the Effective Date or at such time as such legend is no longer
required under this Section 4.1(c), it will, no later than three Trading Days
following the delivery by a Purchaser to the Company or the Company's transfer
agent of a certificate representing Shares or Warrant Shares, as the case may
be, issued with a restrictive legend (such date, the "LEGEND REMOVAL DATE"),
deliver or cause to be delivered to such Purchaser a certificate representing
such Securities that is free from all restrictive and other legends. The Company
may not make any notation on its records or give instructions to any transfer
agent of the Company that enlarge the restrictions on transfer set forth in this
Section.

       

      (d) As
the Purchaser’s exclusive remedy, the Company shall pay to a Purchaser, in cash,
as liquidated damages and not as a penalty, for each $1,000 of Shares or Warrant
Shares (based on the Closing Price of the Common Stock on the date such
Securities are submitted to the Company's transfer agent) subject to Section
4.1(c), $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading
Days after such damages have begun to accrue) for each Trading Day after such
fifth Trading Day after the Legend Removal Date until such certificate is
delivered. Nothing herein shall limit such Purchaser's right to pursue actual
damages for the Company's failure to deliver certificates representing any
Securities as required by the Transaction Documents, and such Purchaser shall
have the right to pursue all remedies available to it at law or in equity
including, without limitation, a decree of specific performance and/or
injunctive relief.

       

      (e) Each
Purchaser, severally and not jointly with the other Purchasers, agrees that the
removal of the restrictive legend from certificates representing Securities as
set forth in this Section 4.1 is predicated upon the Company's reliance that the
Purchaser will sell any Securities pursuant to either the registration
requirements of the Securities Act, including any applicable prospectus delivery
requirements, or an exemption therefrom.

       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

       

      4.2
FURNISHING OF INFORMATION. As long as any Purchaser owns Securities, the Company
covenants to timely file (or obtain extensions in respect thereof and file
within the applicable grace period) all reports required to be filed by the
Company after the date hereof pursuant to the Exchange Act. As long as any
Purchaser owns Securities, if the Company is not required to file reports
pursuant to the Exchange Act, it will prepare and furnish to the Purchasers and
make publicly available in accordance with Rule 144(c) such information as is
required for the Purchasers to sell the Securities under Rule 144. The Company
further covenants that it will take such further action as any holder of
Securities may reasonably request, all to the extent required from time to time
to enable such Person to sell such Securities without registration under the
Securities Act within the limitation of the exemptions provided by Rule
144.

       

      4.3
INTEGRATION. The Company shall not sell, offer for sale or solicit offers to buy
or otherwise negotiate in respect of any security (as defined in Section 2 of
the Securities Act) that would be integrated with the offer or sale of the
Securities in a manner that would require the registration under the Securities
Act of the sale of the Securities to the Purchasers or that would be integrated
with the offer or sale of the Securities for purposes of the rules and
regulations of any Trading Market such that it would require shareholder
approval prior to the closing of such other transaction unless shareholder
approval is obtained before the closing of such subsequent
transaction.

       

      4.4
SECURITIES LAWS DISCLOSURE; PUBLICITY. The Company shall issue a press release
or file a Current Report on Form 8-K, in each case reasonably acceptable to each
Purchaser disclosing the material terms of the transactions contemplated hereby.
The Company and each Purchaser shall consult with each other in issuing any
press releases with respect to the transactions contemplated hereby, and neither
the Company nor any Purchaser shall issue any such press release or otherwise
make any such public statement without the prior consent of the Company, with
respect to any press release of any Purchaser, or without the prior consent of
each Purchaser, with respect to any press release of the Company, which consent
shall not unreasonably be withheld, except if such disclosure is required by
law, in which case the disclosing party shall promptly provide the other party
with prior notice of such public statement or communication. Notwithstanding the
foregoing, the Company shall not publicly disclose the name of any Purchaser, or
include the name of any Purchaser in any filing with the Commission or any
regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (i) as required by federal securities law in connection with
the registration statement contemplated by the Registration Rights Agreement and
(ii) to the extent such disclosure is required by law or Trading Market
regulations, in which case the Company shall provide the Purchasers with prior
notice of such disclosure permitted under subclause (i) or (ii).

       

      4.5
SHAREHOLDERS RIGHTS PLAN. No claim will be made or enforced by the Company or,
to the knowledge of the Company, any other Person that any Purchaser is an
"Acquiring Person" under any shareholders rights plan or similar plan or
arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by
virtue of receiving Securities under the Transaction Documents or under any
other agreement between the Company and the Purchasers. The Company shall
conduct its business in a manner so that it will not become subject to the
Investment Company Act.

       

      4.6
NON-PUBLIC INFORMATION. The Company covenants and agrees that neither it nor any
other Person acting on its behalf will provide any Purchaser or its agents or
counsel with any information that the Company believes constitutes material
non-public information, unless prior thereto such Purchaser shall have executed
a written agreement regarding the confidentiality and use of such information.
The Company understands and confirms that each Purchaser shall be relying on the
foregoing representations in effecting transactions in securities of the
Company.

       

      4.7 USE
OF PROCEEDS. Except as set forth on SCHEDULE 4.7 attached hereto, the Company
shall use the net proceeds from the sale of the Securities hereunder for working
capital purposes and not for the satisfaction of any portion of the Company's
debt (other than payment of trade payables in the ordinary course of the
Company's business and prior practices), to redeem any Company equity or
equity-equivalent securities or to settle any outstanding
litigation.

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      

      4.8
INDEMNIFICATION OF PURCHASERS. The Company will indemnify and hold the
Purchasers and their directors, officers, shareholders, partners, employees and
agents (each, a "PURCHASER PARTY") harmless from any and all losses,
liabilities, obligations, claims, contingencies, damages, costs and expenses,
including all judgments, amounts paid in settlements, court costs and reasonable
attorneys' fees and costs of investigation that any such Purchaser Party may
suffer or incur as a result of or relating to: (a) any misrepresentation, breach
or inaccuracy, or any allegation by a third party that, if true, would
constitute a breach or inaccuracy, of any of the representations, warranties,
covenants or agreements made by the Company in this Agreement or in the other
Transaction Documents; or (b) any cause of action, suit or claim brought or made
against such Purchaser Party and arising solely out of or solely resulting from
the execution, delivery, performance or enforcement of this Agreement or any of
the other Transaction Documents, other than directly resulting from the gross
negligence or willful misconduct of the Purchasers. The Company will reimburse
such Purchaser for its reasonable legal and other expenses (including the cost
of any investigation, preparation and travel in connection therewith) incurred
in connection therewith, as such expenses are incurred.

       

      4.9
RESERVATION OF COMMON STOCK. As of the date hereof, the Company has reserved and
the Company shall continue to reserve and keep available at all times, free of
preemptive rights, a sufficient number of shares of Common Stock for the purpose
of enabling the Company to issue Shares pursuant to this Agreement and Warrant
Shares pursuant to any exercise of the Warrants.

       

      4.10
LISTING OF COMMON STOCK. The Company hereby agrees to use commercially
reasonable efforts to maintain the listing of the Common Stock on a Trading
Market, and as soon as reasonably practicable following the Closing (but not
later than the earlier of the Effective Date and the first anniversary of the
Closing Date) to list all of the Shares and Warrant Shares on such Trading
Market. The Company further agrees, if the Company applies to have the Common
Stock traded on any other Trading Market, it will include in such application
all of the Shares and Warrant Shares, and will take such other action as is
necessary to cause all of the Shares and Warrant Shares to be listed on such
other Trading Market as promptly as possible. The Company will take all action
reasonably necessary to continue the listing and trading of its Common Stock on
a Trading Market and will comply in all respects with the Company's reporting,
filing and other obligations under the bylaws or rules of the Trading
Market.

       

      4.11
EQUAL TREATMENT OF PURCHASERS. No consideration shall be offered or paid to any
person to amend or consent to a waiver or modification of any provision of any
of the Transaction Documents unless the same consideration is also offered to
all of the parties to the Transaction Documents. For clarification purposes,
this provision constitutes a separate right granted to each Purchaser by the
Company and negotiated separately by each Purchaser, and is intended to treat
for the Company the Purchasers as a class and shall not in any way be construed
as the Purchasers acting in concert or as a group with respect to the purchase,
disposition or voting of Securities or otherwise.

       

      4.12
ABSENCE OF OFFICIAL EVALUATION. Purchaser understands
that no federal or state agency has made any finding or determination as to the
fairness of the terms of an investment in the Company, nor any recommendation
for or endorsement of the Shares offered hereby.

       

      ARTICLE
V. MISCELLANEOUS

       

      5.1 FEES
AND EXPENSES. Each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred
by such party incident to the negotiation, preparation, execution, delivery and
performance of this Agreement. The Company shall pay all stamp and other taxes
and duties levied in connection with the sale of the Securities.

       

      5.2
ENTIRE AGREEMENT. The Transaction Documents, together with the exhibits and
schedules thereto, contain the entire understanding of the parties with respect
to the subject matter hereof and supersede all prior agreements and
understandings, oral or written, with respect to such matters, which the parties
acknowledge have been merged into such documents, exhibits and
schedules.

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      5.3
NOTICES. Any and all notices or other communications or deliveries required or
permitted to be provided hereunder shall be in writing and shall be deemed given
and effective on the earliest of (a) the date of transmission, if such notice or
communication is delivered via facsimile at the facsimile number set forth on
the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a
Trading Day, (b) the next Trading Day after the date of transmission, if such
notice or communication is delivered via facsimile at the facsimile number set
forth on the signature pages attached hereto on a day that is not a Trading Day
or later than 6:30 p.m. (New York City time) on any Trading Day, (c) the second
Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (d) upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and communications
shall be as set forth on the signature pages attached hereto.

       

      5.3
AMENDMENTS; WAIVERS. No provision of this Agreement may be waived or amended
except in a written instrument signed, in the case of an amendment, by the
Company and each Purchaser or, in the case of a waiver, by the party against
whom enforcement of any such waiver is sought. No waiver of any default with
respect to any provision, condition or requirement of this Agreement shall be
deemed to be a continuing waiver in the future or a waiver of any subsequent
default or a waiver of any other provision, condition or requirement hereof, nor
shall any delay or omission of either party to exercise any right hereunder in
any manner impair the exercise of any such right.

       

      5.4
CONSTRUCTION. The headings herein are for convenience only, do not constitute a
part of this Agreement and shall not be deemed to limit or affect any of the
provisions hereof. The language used in this Agreement will be deemed to be the
language chosen by the parties to express their mutual intent, and no rules of
strict construction will be applied against any party.

       

      5.5
SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and inure to the
benefit of the parties and their successors and permitted assigns. The Company
may not assign this Agreement or any rights or obligations hereunder without the
prior written consent of each Purchaser. Any Purchaser may assign any or all of
its rights under this Agreement to any Person to whom such Purchaser assigns or
transfers any Securities, provided such transferee agrees in writing to be
bound, with respect to the transferred Securities, by the provisions hereof that
apply to the "Purchasers".

       

      5.6 NO
THIRD-PARTY BENEFICIARIES. This Agreement is intended for the benefit of the
parties hereto and their respective successors and permitted assigns and is not
for the benefit of, nor may any provision hereof be enforced by, any other
Person, except as otherwise set forth in Section 4.8.

       

      5.7
GOVERNING LAW. All questions concerning the construction, validity, enforcement
and interpretation of the Transaction Documents shall be governed by and
construed and enforced in accordance with the internal laws of the State of
Delaware, without regard to the principles of conflicts of law thereof. Each
party agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement and
any other Transaction Documents (whether brought against a party hereto or its
respective affiliates, directors, officers, shareholders, employees or agents)
shall be commenced exclusively in the state and federal courts sitting in the
Miami-Dade or Broward Counties, Florida. Each party hereto hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in
Miami-Dade or Broward Counties, Florida, for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein (including with respect to the enforcement of any of the
Transaction Documents), and hereby irrevocably waives, and agrees not to assert
in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of any such court, that such suit, action or proceeding is
improper. Each party hereto hereby irrevocably waives personal service of
process and consents to process being served in any such suit, action or
proceeding by delivering a copy thereof via overnight delivery (with evidence of
delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law.
Each party hereto (including its affiliates, agents, officers, directors and
employees) hereby irrevocably waives, to the fullest extent permitted by
applicable law, any and all right to trial by jury in any legal proceeding
arising out of or relating to this Agreement or the transactions contemplated
hereby. If either party shall commence an action or proceeding to enforce any
provisions of a Transaction Document, then the prevailing party in such action
or proceeding shall be reimbursed by the other party for its attorneys' fees and
other costs and expenses incurred with the investigation, preparation and
prosecution of such action or proceeding.

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      5.8
SURVIVAL. The representations and warranties herein shall survive the Closing
and delivery of the Shares and Warrant Shares.

       

      5.9
EXECUTION. This Agreement may be executed in two or more counterparts, all of
which when taken together shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and
delivered to the other party, it being understood that both parties need not
sign the same counterpart. In the event that any signature is delivered by
facsimile transmission, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is
executed) with the same force and effect as if such facsimile signature page
were an original thereof.

       

      5.10
SEVERABILITY. If any provision of this Agreement is held to be invalid or
unenforceable in any respect, the validity and enforceability of the remaining
terms and provisions of this Agreement shall not in any way be affected or
impaired thereby and the parties will attempt to agree upon a valid and
enforceable provision that is a reasonable substitute therefor, and upon so
agreeing, shall incorporate such substitute provision in this
Agreement.

       

      5.11
REPLACEMENT OF SECURITIES. If any certificate or instrument evidencing any
Securities is mutilated, lost, stolen or destroyed, the Company shall issue or
cause to be issued in exchange and substitution for and upon cancellation
thereof, or in lieu of and substitution therefor, a new certificate or
instrument, but only upon receipt of evidence reasonably satisfactory to the
Company of such loss, theft or destruction and customary and reasonable
indemnity, if requested. The applicants for a new certificate or instrument
under such circumstances shall also pay any reasonable third-party costs
associated with the issuance of such replacement Securities.

       

      5.12
REMEDIES. In addition to being entitled to exercise all rights provided herein
or granted by law, including recovery of damages, each of the Purchasers and the
Company will be entitled to specific performance under the Transaction
Documents. The parties agree that monetary damages may not be adequate
compensation for any loss incurred by reason of any breach of obligations
described in the foregoing sentence and hereby agrees to waive in any action for
specific performance of any such obligation the defense that a remedy at law
would be adequate.

       

      5.13
PAYMENT SET ASIDE. To the extent that the Company makes a payment or payments to
any Purchaser pursuant to any Transaction Document or a Purchaser enforces or
exercises its rights thereunder, and such payment or payments or the proceeds of
such enforcement or exercise or any part thereof are subsequently invalidated,
declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company,
a trustee, receiver or any other person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable
cause of action), then to the extent of any such restoration the obligation or
part thereof originally intended to be satisfied shall be revived and continued
in full force and effect as if such payment had not been made or such
enforcement or setoff had not occurred.

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      5.14
INDEPENDENT NATURE OF PURCHASERS' OBLIGATIONS AND RIGHTS. The obligations of
each Purchaser under any Transaction Document are several and not joint with the
obligations of any other Purchaser, and no Purchaser shall be responsible in any
way for the performance of the obligations of any other Purchaser under any
Transaction Document. Nothing contained herein or in any Transaction Document,
and no action taken by any Purchaser pursuant thereto, shall be deemed to
constitute the Purchasers as a partnership, an association, a joint venture or
any other kind of entity, or create a presumption that the Purchasers are in any
way acting in concert or as a group with respect to such obligations or the
transactions contemplated by the Transaction Document. Each Purchaser shall be
entitled to independently protect and enforce its rights, including without
limitation, the rights arising out of this Agreement or out of the other
Transaction Documents, and it shall not be necessary for any other Purchaser to
be joined as an additional party in any proceeding for such purpose. Each
Purchaser has been represented by its own separate legal counsel in their review
and negotiation of the Transaction Documents. The Company has elected to provide
all Purchasers with the same terms and Transaction Documents for the convenience
of the Company and not because it was required or requested to do so by the
Purchasers.

       

      (SIGNATURE
PAGE FOLLOWS)

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.

       

      
        
          
            
              	
                      SANSWIRE
      CORP.

                    
	 
      	 
      
	
                      By:

                    	   
      
	 
      	
                      Jonathan
      Leinwand

                    
	 
      	
                      Chief
      Executive Officer

                    

            

          

        

      

       

      Address
for Notice:

       

      Sanswire
Corp.

      c/o
Jonathan Leinwand

      101 NE
3rd
Ave., Suite 1500

      Fort
Lauderdale, FL 33301

       

      [REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK SIGNATURE PAGES FOR PURCHASERS
FOLLOW]

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement
to be duly executed by their respective authorized signatories as of the date
first indicated above.

       

      
        
          
            
              	
                      PURCHASER NAME:

                    
	 
      
	
                      By:

                    	  
      
	
                      Name:

                    
	
                      Title:

                    

            

          

        

      

       

      ADDRESS
FOR NOTICE

      Attn:

       

      Subscription
Amount:

      $

      Shares:

      Warrant
Shares:

       

      WITH A
COPY TO:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}]]